eHealth (EHTH) Aktienübersicht
eHealth, Inc. betreibt einen Marktplatz für Krankenversicherungen, der in den Vereinigten Staaten Lösungen zur Einbindung von Verbrauchern, zur Aufklärung und zur Einschreibung in Krankenversicherungen anbietet. Mehr Details
| Schneeflocken-Punktzahl | |
|---|---|
| Bewertung | 3/6 |
| Künftiges Wachstum | 0/6 |
| Vergangene Leistung | 0/6 |
| Finanzielle Gesundheit | 4/6 |
| Dividenden | 0/6 |
EHTH Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
eHealth, Inc. Wettbewerber
Preisentwicklung & Leistung
| Historische Aktienkurse | |
|---|---|
| Aktueller Aktienkurs | US$1.76 |
| 52-Wochen-Hoch | US$5.89 |
| 52-Wochen-Tief | US$1.20 |
| Beta | 1.57 |
| 1 Monat Veränderung | -4.35% |
| 3 Monate Veränderung | 3.53% |
| 1 Jahr Veränderung | -60.18% |
| 3 Jahre Veränderung | -78.14% |
| 5 Jahre Veränderung | -97.30% |
| Veränderung seit IPO | -92.31% |
Aktuelle Nachrichten und Updates
Narrativ-Update • May 06
EHTH: Softer 2026 Revenue Guide And Benefit Launch Will Shape Outlook
Narrative Update on eHealth Analysts have cut eHealth's average price target from about $5 to roughly $2, citing softer 2026 revenue expectations tied to reduced marketing spend by a major Medicare Advantage payor and cautious assumptions around the next annual enrollment period. Analyst Commentary Bearish analysts have moved quickly to reset expectations on eHealth, cutting price targets and shifting ratings to more neutral stances after the latest outlook.
Narrativ-Update • Apr 22
EHTH: Margin Discipline And New Offerings Will Reframe Long Term Prospects
Analysts have cut their price targets on eHealth significantly, with the consensus fair value moving from about $12.00 to roughly $3.00 as softer 2026 revenue guidance, reduced marketing spend from a major Medicare Advantage payor, and a tougher customer acquisition backdrop weigh on expectations. Analyst Commentary Recent Street research points to a more cautious stance on eHealth, with several firms cutting price targets and resetting expectations after the 2026 revenue guide.Recent updates
Narrativ-Update • May 06
EHTH: Softer 2026 Revenue Guide And Benefit Launch Will Shape Outlook
Narrative Update on eHealth Analysts have cut eHealth's average price target from about $5 to roughly $2, citing softer 2026 revenue expectations tied to reduced marketing spend by a major Medicare Advantage payor and cautious assumptions around the next annual enrollment period. Analyst Commentary Bearish analysts have moved quickly to reset expectations on eHealth, cutting price targets and shifting ratings to more neutral stances after the latest outlook.Narrativ-Update • Apr 22
EHTH: Margin Discipline And New Offerings Will Reframe Long Term Prospects
Analysts have cut their price targets on eHealth significantly, with the consensus fair value moving from about $12.00 to roughly $3.00 as softer 2026 revenue guidance, reduced marketing spend from a major Medicare Advantage payor, and a tougher customer acquisition backdrop weigh on expectations. Analyst Commentary Recent Street research points to a more cautious stance on eHealth, with several firms cutting price targets and resetting expectations after the 2026 revenue guide.
Narrativ-Update • Apr 07
EHTH: Conservative 2026 Guide And Marketing Pullback Will Support Margin Repair
Analysts have cut the average price target on eHealth to about $2 to $3 per share, down sharply from prior targets near $8 to $9. They cite softer 2026 revenue guidance tied to reduced marketing spend by a key Medicare Advantage payor, conservative assumptions for the next annual enrollment period, and a planned pullback in some customer acquisition channels.Narrativ-Update • Mar 24
EHTH: Conservative 2026 Revenue Guide Will Support Margin Focused Turnaround
Analysts have cut the average price target for eHealth by $1.50, citing softer than expected 2026 revenue guidance, reduced marketing spend by a major Medicare Advantage payor, and company plans to scale back certain customer acquisition channels while carriers remain focused on margins. Analyst Commentary Recent Street research reflects a more cautious stance on eHealth, with several firms cutting price targets and resetting expectations following the 2026 revenue guidance.Narrativ-Update • Mar 10
EHTH: Higher 2025 Earnings Guidance Will Support Margin Focused Turnaround
Analysts have sharply cut their average price target on eHealth from about $8.50 to roughly $3.75, reflecting lower $2 targets and a focus on weaker revenue expectations, along with an increased emphasis on margins and reduced customer acquisition spending. Analyst Commentary Recent research notes on eHealth highlight a meaningful reset in expectations, with price targets clustered around $2 and ratings largely at Hold.Narrativ-Update • Feb 24
EHTH: Higher 2025 Earnings Guidance Will Support Future Performance
Analysts have modestly adjusted their price target on eHealth to reflect a slightly higher discount rate and a small change in the assumed future P/E multiple, while keeping fair value steady at $8.50 as they reassess risk and valuation inputs without new Street research catalysts. What's in the News eHealth updated its earnings guidance for the year ending December 31, 2025, with total revenue now expected in a range of $540.0 million to $560.0 million, compared with the prior range of $525.0 million to $565.0 million (Key Developments).Analyseartikel • Feb 10
Market Cool On eHealth, Inc.'s (NASDAQ:EHTH) Revenues Pushing Shares 48% Lower
The eHealth, Inc. ( NASDAQ:EHTH ) share price has fared very poorly over the last month, falling by a substantial 48...Narrativ-Update • Feb 09
EHTH: Enrollment Strength And Softer Competition Will Support Future Performance
Analysts have trimmed their price target on eHealth to US$9 from US$10, citing price adjustments even as the annual enrollment period tracks in line with expectations, supported by solid consumer demand and early signs of a more favorable competitive backdrop. Analyst Commentary Bullish Takeaways Bullish analysts point to the annual enrollment period tracking in line with internal expectations, which they see as a sign that execution is holding up against current industry conditions.Narrativ-Update • Jan 26
EHTH: Solid Enrollment Trends And Easing Competition Will Support Future Margins
Analysts have trimmed their price target on eHealth to US$9 from US$10, citing annual enrollment trends that are tracking in line with expectations, along with signs of steady consumer demand and a somewhat more favorable competitive backdrop. Analyst Commentary Recent commentary around the price target cut frames eHealth as a company where execution looks generally on track, but with a valuation reset to reflect a more balanced risk and reward profile.Narrativ-Update • Jan 11
EHTH: Solid Enrollment Trends And Healthier Competition Will Support Margin Expansion
Analysts trimmed their price target on eHealth to US$9 from US$10, citing annual enrollment trends that are tracking in line with expectations, solid consumer demand on the platform, and early indications of a more favorable competitive environment. Analyst Commentary Analysts see a mixed picture for eHealth at the current US$9 price target, with solid execution on core drivers balanced against questions on how much upside is justified in the near term.Narrativ-Update • Dec 24
EHTH: Strengthening Enrollment Trends Will Support Future Margin Expansion Potential
Analysts have trimmed their price target on eHealth from $10.00 to $9.00 per share, citing in-line annual enrollment trends supported by strong platform demand and early signs of a more favorable competitive environment. Analyst Commentary Bullish Takeaways Bullish analysts highlight that the annual enrollment period is progressing in line with internal expectations, reinforcing confidence in management’s guidance and execution.Analyseartikel • Dec 19
Further Upside For eHealth, Inc. (NASDAQ:EHTH) Shares Could Introduce Price Risks After 35% Bounce
eHealth, Inc. ( NASDAQ:EHTH ) shareholders would be excited to see that the share price has had a great month, posting...Narrativ-Update • Dec 10
EHTH: Improving Enrollment Dynamics Will Support Future Upside Potential
Analysts have trimmed their price target on eHealth to $9 from $10, citing an annual enrollment period that is tracking in line with expectations, supported by solid consumer demand and a gradually improving competitive landscape. Analyst Commentary Analysts view the latest price target revision as a reflection of balanced expectations for eHealth, incorporating both the progress made in the current enrollment cycle and the lingering execution and competitive risks that could affect future growth and valuation.Narrativ-Update • Nov 26
EHTH: Future Enrollment Trends Will Support Further Upside Potential
Narrative Update on eHealth: Analyst Price Target Revised Analysts have slightly reduced their price target for eHealth, lowering it from $8.75 to $8.50. This revision is due to a modest decrease in revenue growth outlook and a marginally higher discount rate.Narrativ-Update • Nov 12
EHTH: Future Profit Margins Will Drive Upside Despite Consumer Confusion
Analysts have revised their price target for eHealth down from $9.25 to $8.75. They cite a significant reduction in projected profit margin, even though revenue growth forecasts have slightly improved and the estimated future price-to-earnings ratio is notably higher.Seeking Alpha • Nov 08
eHealth: Undervalued And Gaining Momentum After Q3 Earnings Beat
Summary eHealth Inc. is positioned for a turnaround, leveraging digital platform enhancements, cost optimization, and strong insurer partnerships. EHTH trades at a deep discount to peers despite improved financials, nearly debt-free balance sheet, and superior liquidity and margins. Key risks include seasonality, regulatory changes, and competition, but Q3 earnings and open enrollment are positive signs of a turnaround. We rate EHTH a BUY, expecting a rebound to tangible book value ($14-$18/share) if FY25 guidance is met or exceeded. Read the full article on Seeking AlphaAnalyseartikel • Oct 28
eHealth, Inc. (NASDAQ:EHTH) Held Back By Insufficient Growth Even After Shares Climb 34%
Despite an already strong run, eHealth, Inc. ( NASDAQ:EHTH ) shares have been powering on, with a gain of 34% in the...Analyseartikel • Sep 03
eHealth, Inc. (NASDAQ:EHTH) Surges 26% Yet Its Low P/S Is No Reason For Excitement
Those holding eHealth, Inc. ( NASDAQ:EHTH ) shares would be relieved that the share price has rebounded 26% in the last...Analyseartikel • Aug 09
The eHealth, Inc. (NASDAQ:EHTH) Second-Quarter Results Are Out And Analysts Have Published New Forecasts
NasdaqGS:EHTH 1 Year Share Price vs Fair Value Explore eHealth's Fair Values from the Community and select yours...Analyseartikel • May 15
eHealth, Inc.'s (NASDAQ:EHTH) 26% Dip In Price Shows Sentiment Is Matching Revenues
Unfortunately for some shareholders, the eHealth, Inc. ( NASDAQ:EHTH ) share price has dived 26% in the last thirty...
Neues Narrativ • Mar 31
Medicare Focus And AI Projects Will Improve Operations
Revenue and earnings growth driven by increased Medicare submissions, marketing investments, and enhanced enrollment margins.Analyseartikel • Mar 16
Benign Growth For eHealth, Inc. (NASDAQ:EHTH) Underpins Stock's 30% Plummet
The eHealth, Inc. ( NASDAQ:EHTH ) share price has softened a substantial 30% over the previous 30 days, handing back...Seeking Alpha • Feb 26
eHealth: Another Big Run, Lock In, And Run House Money
Summary eHealth, Inc. was recommended at $6.78; now, with current gains to above $9, we suggest you lock in profits and hold EHTH stock for long-term growth. eHealth showed strong Q4 performance, but it was an outlier. We like EHTH shares for long-term exposure, but 2025 at best looks flat from 2024. Consider a house position after the rapid-return trade. Read the full article on Seeking AlphaAnalyseartikel • Dec 23
Market Might Still Lack Some Conviction On eHealth, Inc. (NASDAQ:EHTH) Even After 66% Share Price Boost
eHealth, Inc. ( NASDAQ:EHTH ) shares have continued their recent momentum with a 66% gain in the last month alone. Not...Seeking Alpha • Dec 17
Bull Run For EHealth, Inc.: Stock Flying On Solid Enrollment
Summary eHealth, Inc. is an online health insurance marketplace with strong enrollment, particularly in Medicare plans, aided by new technologies and live assistance. Despite a 90%+ drop from its 2020 peak, Q3 2024 showed signs of improvement, with a 16% decline in acquisition costs and a 6% reduction in adjusted net loss. Significant growth in submitted Medicare applications and a new member retention program have led to raised revenue and profit guidance for 2024. EHTH stock, is likely heading to double digits in 2025, driven by improved outlook and retention strategies. Read the full article on Seeking AlphaAnalyseartikel • Nov 08
A Piece Of The Puzzle Missing From eHealth, Inc.'s (NASDAQ:EHTH) 31% Share Price Climb
The eHealth, Inc. ( NASDAQ:EHTH ) share price has done very well over the last month, posting an excellent gain of 31...Analyseartikel • Aug 30
Positive Sentiment Still Eludes eHealth, Inc. (NASDAQ:EHTH) Following 25% Share Price Slump
To the annoyance of some shareholders, eHealth, Inc. ( NASDAQ:EHTH ) shares are down a considerable 25% in the last...Aktionärsrenditen
| EHTH | US Insurance | US Markt | |
|---|---|---|---|
| 7D | -6.9% | 0.9% | -0.3% |
| 1Y | -60.2% | -10.5% | 24.0% |
Rendite im Vergleich zur Industrie: EHTH unter dem Niveau der Branche US Insurance , die im vergangenen Jahr eine Rendite von -10.5% erzielte.
Rendite vs. Markt: EHTH hinter dem Markt US zurück, der im vergangenen Jahr eine Rendite von 24 erzielte.
Preisvolatilität
| EHTH volatility | |
|---|---|
| EHTH Average Weekly Movement | 16.3% |
| Insurance Industry Average Movement | 4.3% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.1% |
Stabiler Aktienkurs: Der Aktienkurs von EHTH war in den letzten 3 Monaten im Vergleich zum US -Markt volatil.
Volatilität im Zeitverlauf: EHTHDie wöchentliche Volatilität (16%) war im vergangenen Jahr stabil, liegt aber immer noch höher als bei 75 % der US Aktien.
Über das Unternehmen
| Gegründet | Mitarbeiter | CEO | Website |
|---|---|---|---|
| 1997 | 1,665 | Derrick Duke | www.ehealthinsurance.com |
eHealth, Inc. betreibt einen Marktplatz für Krankenversicherungen, der in den Vereinigten Staaten Lösungen zur Einbindung von Verbrauchern, zur Aufklärung und zur Einschreibung in Krankenversicherungen anbietet. Das Unternehmen ist in zwei Segmenten tätig: Medicare sowie Arbeitgeber und Einzelpersonen. Das Segment Medicare bietet den Verkauf von Medicare-bezogenen Krankenversicherungsplänen, wie Medicare Advantage, Medicare Supplement und Medicare Part D verschreibungspflichtige Arzneimittelpläne für Medicare-berechtigte Personen, einschließlich, aber nicht beschränkt auf, Zahn- und Sehkraftversicherungen und Krankenhausentschädigungspläne, sowie Werbeprogramme für Marketing und andere Dienstleistungen.
eHealth, Inc.'s Grundlagenzusammenfassung
| EHTH grundlegende Statistiken | |
|---|---|
| Marktanteil | US$55.86m |
| Gewinn(TTM) | -US$18.54m |
| Umsatz(TTM) | US$528.91m |
0.1x
Kurs-Umsatz-Verhältnis-3.0x
Kurs-Gewinn-Verhältnis Ist EHTH zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
| EHTH Gewinn- und Verlustrechnung (TTM) | |
|---|---|
| Einnahmen | US$528.91m |
| Kosten der Einnahmen | US$0 |
| Bruttogewinn | US$528.91m |
| Sonstige Ausgaben | US$547.45m |
| Gewinn | -US$18.54m |
Zuletzt gemeldete Gewinne
Mar 31, 2026
Datum des nächsten Gewinnberichts
k.A.
| Gewinn per Aktie (EPS) | -0.58 |
| Bruttomarge | 100.00% |
| Nettogewinnspanne | -3.51% |
| Schulden/Eigenkapital-Verhältnis | 11.7% |
Wie hat sich EHTH auf lange Sicht entwickelt?
Historische Performance und VergleicheUnternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/05/17 15:20 |
| Aktienkurs zum Tagesende | 2026/05/15 00:00 |
| Gewinne | 2026/03/31 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
eHealth, Inc. wird von 25 Analysten beobachtet. 5 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Steven Valiquette | Barclays |
| Steven Valiquette | Barclays |
| Nathaniel Schindler | BofA Global Research |